Negative regulation of vasculature development

pathway activity — cross-omics
GO:1901343Cross-omicsRNA → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of vasculature development pathway is significantly associated with the RNA expression of multiple genes, with the TGCT cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CD93, CRISPLD2, and PDGFRB, each associated with the pathway in up to 34 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of vasculature development activity versus CD93 in TGCT (Pearson r = 0.78).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
TGCTCD93 →+1.725+0.045<.001<.001334
LIHCCRISPLD2 →+1.592+0.032<.001<.001333
CHOLPDGFRB →+2.014+0.069<.001<.001333
TGCTNID1 →+2.157+0.042<.001<.001333
MESOTEK →+1.534+0.036<.001<.001333
MESOMYCT1 →+1.534+0.043<.001<.001333
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1901343 vs CD93 — TGCT

Per-sample scatter of Negative regulation of vasculature development activity vs CD93 in TGCT.

Explore this scatter interactively →

Exploration